FELODIPINE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

FELODIPINE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses



IUPAC nomenclature

(RS)-3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate.


  • Dihydropyridines
  • Calcium channel blockers


Physiochemical Properties

1 Molecular weight 384.2 g/mol
2 Physical appearance Solid
3 Melting point 145oC
4 Solubility 19.7mg/L
5 Octanol/water partition coefficient 3.86
5 Presence of ring Dihydropyridine, phenyl
6 Number of chiral centers 1



Mechanism of Action

  • The influx of calcium ions through voltage gated L-type calcium channels is inhibited by Felodipine which results in decrease in the arterial smooth muscle contractility and subsequent vasoconstriction.
  • This inhibition results in overall decrease in blood pressure.


Structure Activity Relationship

General structure activity of dihydropyridines calcium channel blockers can be summarized as:

  • R1 should be unsubstituted.
  • R1 should be easily detachable group.
  • Basic amino ethyl ether chain at R2 increases the potency of drug, while H/aryl group results in loss of activity of drug.
  • Substitution of R3 and R5 with alkoxy carbonyl group gives optimum activity.
  • Branching of alkyl chain of ester group decreases the activity.
  • R4 must be phenyl ring.
  • S-enantiomers are more active than R-enantiomers.


Method of synthesis

i. Methylacetoacetate reacts with 2,3-dichlorobenzaldehyde to give methyl-2-(2,3-dichlorobenzyidene)-acetoacetate.

ii. The last is reacted with ethylacetoacetate in presence of ammonia to give felodipine. [1]

Medicinal Uses

Felodipine is used for the treatment of:

  • Mild hypertension
  • Moderate hypertension 


Side Effects

Side effects of felodipine are:

  • Dizziness
  • Weakness
  • Flushing
  • Fainting
  • Lightheadedness
  • Swelling of ankles
  • Constipation
  • Headache
  • Stomach upset
  • Allergic reactions 



Q.1 What can be the correct IUPAC nomenclature of Felodipine?

a) 6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

b) 1,4:3,6-dianhydro-2,5-di-O-nitro-D-propanol.

c) 1-[(4-Chlorophenyl)(phenyl)methyl]-4-methylpiperazine

d) (RS)-3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Q.2 Which amongst the following statements is/are correct related to the SAR of Dihydropyridines calcium channel blockers?

I. Branching of alkyl chain of ester group decreases the activity.

II. R4 must be phenyl ring.

III. S-enantiomers are more active than R-enantiomers.

a) I, III

b) II, III

c) I, II

d) I, II, III

Q.3 The correct order for the synthesis of drug Felodipine from Methyl acetoacetate can be?

I. Reaction with 2,3-dichlorobenzaldehyde

II. Sulfonylchlorination

III. Reaction with ammonia

IV. Reaction with ethylacetoacetate

a) I – IV

b) I – II

c) III – II

d) I – IV – III

Q.4 Side effects of drug Felodipine is/are?

a) Dizziness

b) Diarrhea

c) Muscle spasms

d) All of the above

Q.5 Match the following drugs with their correct Octanol water partition coefficient-

i. Felodipine A. 2.05
ii. Pantaprazole B. 1.9
iii. Omeprazole C. 3.86
iv. Polythiazide D. 2.23

 a) i-C, ii-B, iii-A, iv-D

b) i-C, ii-A, iii-D, iv-B

c) i-A, ii-D, iii-C, iv-B

d) i-A, ii-C, iii-B, iv-D

Q.6 An example of drug from class calcium channel blockers?

a) Felodipine

b) Prazosin

c) Hydroxyamphetamine

d) Pseudoephedrine

Q.7 The type of ring system found in the structure of drug Felodipine is?

a) Dihydroopyridine

b) Benzothiazine

c) Naphthalene

d) Pyrimidine




For More Standard and Quality Question Bank you can Join Our Test Series Programme for GPAT, NIPER JEE, Pharmacist Recruitment Exam, Drug Inspector Recruitment Exams, PhD Entrance Exam for Pharmacy

Participate in Online FREE  GPAT  TEST: CLICK HERE

  Participate in Online FREE  Pharmacist  TEST: CLICK HERE 

Participate in Online FREE  Drug Inspector  TEST: CLICK HERE 

Participate in CSIR NET JRF Mock Test

Participate GATE Mock Test















[1] EP 311 582 (Hässle; appl. 22.9.1988; S-prior. 8.10.1987).

Leave a Reply

Your email address will not be published. Required fields are marked *

Free Video Lectures of Pharmacy Exams
Watch now
Admission open 2024 Clinical Research & Pharmacovigilance Courses
Apply now

Developed By Connect Globes